
Ionic Digital's Nasdaq direct listing is a trading event, not a subscription opportunity; the U.S. retail allocation table is empty, Zhongji InnoLight has moved from Hong Kong subscription to final pricing, and Reformation, Jersey Mike's, and Apnimed remain on the near-term radar.
| Ticker | Price range or terms | Minimum buy-in | Deadline | Verified brokers | Status |
|---|---|---|---|---|---|
| None verified | Not available | Not applicable | No verified open U.S. window | None publicly verified | Watch only |
| HK public offer | Offer status | Final price | Board lot | Deadline | Listing |
|---|---|---|---|---|---|
| Zhongji InnoLight | Closed July 27 | HK$980 | 50 shares, historical lot | Closed; no new window | July 30 |
| None else verified | No open offer | Not available | Not available | None verified | Not available |
| Name | Expected pricing | Expected listing or trade | Terms | Why it matters |
|---|---|---|---|---|
| Reformation (REF) | July 29, calendar estimate | July 30, calendar estimate | $15-$17; 14.0625 million shares; about $225 million | A recognizable direct-to-consumer fashion brand with a fresh SEC filing. The filing includes both company shares and selling-stockholder shares, so readers should separate new capital from secondary selling. 67 |
| Jersey Mike's (JMKE) | July 30, reported estimate | July 30, calendar estimate | $21-$25; 43.5 million shares; about $1 billion | The largest recognizable U.S. consumer deal in the current group, with a large secondary component and no verified mainstream retail allocation. 89 |
| Apnimed (APMD) | July 30, calendar estimate | July 31, calendar estimate | $14-$16; 10 million shares; about $150 million | A late-stage sleep-apnea drug developer, where the product approval timeline matters more than a simple growth multiple. The SEC filing still presents the price as a range, not a final print. 1011 |
nasdaqtrader.com
renaissancecapital.com
renaissancecapital.com
au.finance.yahoo.com
finance.sina.cn
sec.gov
iposcoop.com
iposcoop.com
investing.com
sec.gov
iposcoop.com
nyse.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.